Found 0 matching trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
PHASE3To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i....
Status
Active Not Recruiting
Location
UAB Childrens Hospital Harbor Center Neurology Dept
Immune Reconstitution of Immunosuppressed Sepsis Patients
PHASE2A multicenter, randomized, double-blinded, placebo-controlled study of two ...
Location
CHU LIMOGES Service de Réanimation
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
PHASE4This study is to find out if there is any benefit to adding Simvastatin to ...
Location
Coordinating Research Site
A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults
PHASE1The primary purpose of this study is to evaluate safety/ reactogenicity of ...
Location
Floridian Clinical Research LLC
Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)
PHASE3This study aims to evaluate the safety and tolerability of clesrovimab comp...
Location
Miller Children's & Women's Hospital Long Beach ( Site 0001)
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647
PHASE1The main objective of this study is to evaluate the safety, reactogenicity,...
Location
Velocity Clinical Research
Intradermal Rabies Immunization Using NanoJect: A Comparative Study
PHASE1The study is planned as a single-center, randomized, double-blind placebo-c...
Location
Multiple Locations
A Study of S-268019 for the Prevention of COVID-19
PHASE3The main purpose of this study is to assess the efficacy of S-268019-b for ...
Location
Buon Ma Thuot City Medical Center
Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)
PHASE1This study will evaluate the safety, tolerability, and immunogenicity of va...
Location
Multiple Locations
A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers
PHASE2"Multimeric-001" (M-001) has been recently developed, containing conserved,...
Location
Hadassah medical center